Simon M F, Chap H
INSERM Unité 101, Biochimie des Lipides, Hôpital Purpan, Toulouse, France.
J Cardiovasc Pharmacol. 1989;14 Suppl 11:S106-10.
A previous study revealed that elevation of platelet cyclic GMP induced by a pharmacological activator of soluble guanylate cyclase, 3-morpholinosydnonimine (SIN-1), induced a major inhibition of Ca2+ influx caused by thrombin, as detected by monitoring the fluorescence of the Ca2+ indicator quin-2. In contrast, activation of phospholipase C as well as Ca2+ mobilization presumably promoted by inositol-1,4,5-trisphosphate was less affected by SIN-1 treatment. In the present study, the effects of SIN-1 on Ca2+ influx have been investigated in more detail using platelets loaded with millimolar concentrations of quin-2. Under these conditions, Ca2+ entry from the medium into the platelet cytoplasm could be followed either by detecting fluorescence quenching by Mn2+ or by determination of 45Ca2+ uptake. Both events were inhibited by SIN-1 in a dose-dependent manner. Furthermore, the inhibition of 45Ca2+ uptake and of fluorescence increase observed in the presence of extracellular Ca2+ displayed remarkably parallel dose-response curves, suggesting that elevation of cyclic GMP brought about by SIN-1 inhibits the opening of "receptor-operated channels" whose precise nature remains to be determined.
先前的一项研究表明,可溶性鸟苷酸环化酶的药理学激活剂3-吗啉代辛二亚胺(SIN-1)诱导的血小板环鸟苷酸升高,可导致凝血酶引起的Ca2+内流受到主要抑制,这是通过监测Ca2+指示剂quin-2的荧光检测到的。相比之下,磷脂酶C的激活以及可能由肌醇-1,4,5-三磷酸促进的Ca2+动员受SIN-1处理的影响较小。在本研究中,使用加载了毫摩尔浓度quin-2的血小板更详细地研究了SIN-1对Ca2+内流的影响。在这些条件下,通过检测Mn2+引起的荧光猝灭或通过测定45Ca2+摄取,可以追踪Ca2+从培养基进入血小板细胞质的过程。这两个事件均被SIN-1以剂量依赖性方式抑制。此外,在细胞外Ca2+存在下观察到的45Ca2+摄取抑制和荧光增加显示出明显平行的剂量反应曲线,表明SIN-1引起的环鸟苷酸升高抑制了“受体操纵通道”的开放,其确切性质仍有待确定。